Outbreak of multi-resistant Klebsiella oxytoca involving strains with extended-spectrum β-lactamases and strains with extended-spectrum activity of the chromosomal β-lactamase

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 5, 2004, Pages 881-888

  Decré, Dominique ^a,b   Burghoffer, Béatrice ^a   Gautier, Valérie ^a   Petit, Jean Claude ^a,b   Arlet, Guillaume ^a,c  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c HÔPITAL TENON   (France)

Author keywords

OXY 2 lactamase; TEM 129; TEM 7

Indexed keywords

ALANINE; AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; GENTAMICIN; GLUTAMIC ACID; IMIPENEM; KANAMYCIN; LYSINE; NETILMICIN; PIPERACILLIN; PROLINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE; SULFAMETHOXAZOLE; TAZOBACTAM; TOBRAMYCIN;

AGAR GEL DIFFUSION; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DILUTION; ENZYME ACTIVITY; EPIDEMIC; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; KLEBSIELLA OXYTOCA; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; STRAIN DIFFERENCE;

BETA-LACTAMASES; CHROMOSOMES, BACTERIAL; CONJUGATION, GENETIC; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; ELECTROPHORESIS, GEL, PULSED-FIELD; KLEBSIELLA OXYTOCA; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION;

EID: 8844245593     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh440     Document Type: Article

References (43)

1. Beaugerie, L. & Petit, J. C. (2004). Antibiotic-associated diarrhoea. Best Practice & Research. Clinical Gastroenterology 18, 337-52.
2. Podschun, R. & Ullmann, U. (1998). Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clinical Microbiology Reviews 11, 589-603.
3. Wu, S. W., Dornbusch, K. & Kronvall, G. (1999). Genetic characterization of resistance to extended-spectrum β-lactams in Klebsiella oxytoca isolates recovered from patients with septicemia at hospitals in the Stockholm area. Antimicrobial Agents and Chemotherapy 43, 1294-7.
4. Jeong, S. H., Kim, W. M., Chang, C. L. et al. (2001). Neonatal intensive care unit outbreak caused by a strain of Klebsiella oxytoca resistant to aztreonam due to overproduction of chromosomal β-lactamase. Journal of Hospital Infection 48, 281-8.
5. Livermore, D. M. (1995). β-Lactamases in laboratory and clinical resistance. Clinical Microbiology Reviews 8, 557-84.
6. OXY-2. Antimicrobial Agents and Chemotherapy 40, 454-9.
7. Fournier, B. & Roy, P. H. (1997). Variability of chromosomally encoded β-lactamases from Klebsiella oxytoca. Antimicrobial Agents and Chemotherapy 41, 1641-8.
8. Bush, K., Jacoby, G. A. & Meideros, A. A. (1995). A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrobial Agents and Chemotherapy 39, 1211-33.
9. Ambler, R. P., Coulson, A. F. W., Frère, J. M. et al. (1991). A standard numbering scheme for the class A β-lactamases. Biochemical Journal 276, 269-70.
10. OXY-3. Antimicrobial Agents and Chemotherapy 47, 2922-8.
11. Philippon, A., Labia, R. & Jacoby, G. (1989). Extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 33, 1131-6.
12. Bradford, P. A. (2001). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clinical Microbiology Reviews 14 933-51.
13. Arakawa, Y., Ohta, M., Kido, N. et al. (1989). Chromosomal β-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum β-lactam antibiotics. Antimicrobial Agents and Chemotherapy 33, 63-70.
14. Fournier, B., Arlet, G., Lagrange, P. H. et al. (1994). Klebsiella oxytoca: resistance to aztreonam by overproduction of the chromosomally encoded β-lactamase. FEMS Microbiology Letters 116, 31-6.
15. Fournier, B., Lu, C. Y., Lagrange, P. et al. (1995). Point mutation in the pribnow box, the molecular basis of β -lactamase overproduction in Klebsiella oxytoca. Antimicrobial Agents and Chemotherapy 39, 1365-8.
16. Fournier, B., Lagrange, P. & Philippon, A. (1996). β-Lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca. Antimicrobial Agents and Chemotherapy 40, 460-3.
17. Fournier, B., Gravel, A., Hooper, C. et al. (1999). Strength and regulation of the different promoters for chromosomal β-lactamases of Klebsiella oxytoca. Antimicrobial Agents and Chemotherapy 43, 853-5.
18. Mammeri, H., Poirel, L. & Nordmann, P. (2003). In vivo selection of a chromosomally encoded β-lactamase variant conferring ceftazidime resistance in Klebsiella oxytoca. Antimicrobial Agents and Chemotherapy 47, 3739-42.
19. Versalovic, J., Koeuth, T. & Lupski, J. R. (1991). Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Research 19 6823-31.
20. Decré, D., Gachot, B., Lucet, J. C. et al. (1998). Clinical and bacteriologic epidemiology of extended-spectrum β-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit. Clinical Infectious Diseases 27, 834-44.
21. Tenover, F. C., Arbeit, R. D., Goering, R. V. et al. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of Clinical Microbiology 33, 2233-9.
22. Sanger, F., Nicklen, S. & Coulson, A. R. (1977). DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, USA 74, 5463-7.
23. Peason, W. R. & Lipman, D. J. (1988). Improved tools for biological sequence comparison. Proceedings of the National Academy of Sciences, USA 85, 2444-8.
24. Altschul, S. F., Gish, W., Miller, W. et al. (1990). Basic local alignment search tool. Journal of Molecular Biology 215, 403-10.
25. Altschul, S. F., Madden, T. L., Schäffer, A. A. et al. (1997). Gapped BLAST and PSI-BLAST: a new generation of protein data-base search programs. Nucleic Acids Research 25, 3389-402.
26. Kado, C. I. & Lui, S. T. (1981). A rapid procedure for detection and isolation of large and small plasmids. Journal of Bacteriology 145, 1365-73.
27. Chang, A. C. Y. & Cohen, S. N. (1978). Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. Journal of Bacteriology 134 1141-56.
28. Olive, D. M. & Bean, P. (1999). Principles and applications of methods for DNA-based typing of microbial organisms. Journal of Clinical Microbiology 37, 1661-9.
29. Goering, R. V. (1993). Molecular epidemiology of nosocomial infection: analysis of the chromosomal restriction fragment patterns by pulsed-field gel electrophoresis. Infection Control and Hospital Epidemiology 14, 595-600.
30. Toldos, C. M., Ortiz, G., Camara, M. et al. (1997). Application of pulsed-field gel electrophoresis in an outbreak of infections due to Klebsiella oxytoca. Journal of Medical Microbiology 46, 889-90.
31. Tzouvelekis, L. S., Tzelepi, E., Tassios, P. T. et al. (2002). CTX-M-type β-lactamases: an emerging group of extended-spectrum enzyme. International Journal of Antimicrobial Agents 14, 137-42.
32. Bonnet, R. (2004). Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrobial Agents and Chemotherapy 48, 1-14.
33. Sirot, D., Labia, R., Pouedras, P. et al. (1998). Inhibitor-resistant OXY-2 derived β-lactamase produced by Klebsiella oxytoca. Antimicrobial Agents and Chemotherapy 47, 3739-42.
34. Humeniuk, C., Arlet, G., Gautier, V. et al. (2002). β-Lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types. Antimicrobial Agents and Chemotherapy 46, 3045-8.
35. Decousser, J. W., Poirel, L. & Nordmann, P. (2001). Characterization of a chromosomally encoded extended-spectrum class A β-lactamase from Kluyvera cryocrescens. Antimicrobial Agents and Chemotherapy 45, 3595-8.
36. Poirel, L., Kämpfer, P. & Nordmann, P. (2002). Chromosome-encoded Ambler class A β-lactamase of Kluyvera georgiana a probable progenitor of a subgroup of CTX-M extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 46, 4038-40.
37. Peduzzi, J., Reynaud, A., Baron, P. et al. (1994). Chromosomally encoded cephalosporin-hydrolyzing β-lactamase of Proteus vulgaris RO104 belongs to Ambler's class A. Biochimica et Biophysica Acta 1207, 31-9.
38. Peduzzi, J., Farzaneh, S., Raynaud, A. et al. (1997). Characterization and amino acid sequence analysis of a new oxyimino cephalosporin-hydrolyzing class A β-lactamase from Serratia fonticola CUV. Biochimica et Biophysica Acta 1341, 58-70.
39. Petrella, S., Clermont, D., Casin, I. et al. (2001). Novel class A β-lactamase Sed-1 from Citrobacter sedlakii: genetic diversity of β-lactamases within the Citrobacter genus. Antimicrobial Agents and Chemotherapy 45, 2287-98.
40. . Bellais, S., Poirel, L., Fortineau, N. et al. (2001). Biochemical-genetic characterization of chromosomally encoded extended-spectrum class A β-lactamase from Rahnella aquatilis. Antimicrobial Agents and Chemotherapy 45, 2965-8.
41. Vimont, S., Poirel, L., Naas, T. et al. (2002). Identification of a chromosome-borne expanded-spectrum class A β-lactamase from Erwinia persicina. Antimicrobial Agents and Chemotherapy 46, 2401-5.
42. Beauchef-Harvard, A., Arlet, G., Gautier, V. et al. (2003). Molecular and biochemical characterization of a novel class A β-lactamase (HER-1) from Escherichia hermannii. Antimicrobial Agents and Chemotherapy 47, 2669-73.
43. Poirel, L., Naas, T., Le Thomas, I. et al. (2001). CTX-M-type extended-spectrum β-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrobial Agents and Chemotherapy 45, 3335-61.